DataMEDS AI, Inc. MEDS
0.74 USD -0.13 (-14.51%)
At closeNov 13, 2026, 7:41 PM EST
0.68 -0.07 -8.75%
After hours · Nov 13, 7:41 PM ET
0.555 Day range 1.08
0.555 52-week range 35.50
- YTD
- -96.28%
- 1 year
- -97.29%
News
benzinga.com FDA Flags Potential Vision Loss Risk With GLP-1 Drugs, Requiring Weight-Loss Medicines Like Wegovy and Zepbound to Carry New Warning FDA requires new NAION eye warning on all GLP-1 drugs, citing potential increased risk.
benzinga.com DataMeds AI's Corexa Pharmacy Unit Completes First Commercial Sale Of One Of Six FDA-Recommended Peptides Corexa Pharmacy subsidiary has completed its first commercial sale of one of the six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax, together the "Six Peptides") recommended by the U.S.…
benzinga.com Datavault AI Fires CEO Nathaniel Bradley Datavault AI ousts CEO Nathaniel Bradley amid scrutiny over a $150M Bitcoin deal restatement and going-concern risks. Get the latest.
benzinga.com DataMeds AI Signs MoU With Florida HMO To Deploy The Health Lives Here Mobile App For GLP-1 Management DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
benzinga.com DataMeds AI Terminates Second Amended LOI With Datavault AI And Partners Due To Market Conditions; No Shares To Be Issued Under LOI, Existing REBOOT And Datavault Agreements Remain In Effect; Co Does Not Owe Any Fees Or Obligation As A Result Of The Termination DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
benzinga.com DataMEDS AI Moves Into Growing Peptide Market DataMEDS AI (MEDS) unit Corexa Health secures API supply for six peptides to begin dispensing in November 2026.
benzinga.com DataMeds AI's Pharmacy Unit Corexa Health Enters Agreement For Commercial Supply Of Six Peptides Recommended By The FDA Pharmacy Compounding Advisory Committee; Intends To Start Distributing Prescriptions In November 2026 DataMEDS intends to leverage the Health Lives Here mobile application to help collect and report safety data, in accordance with U.S. Health and Human Services' (HHS) Enforcement Discretion Policy…
benzinga.com DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim to bring best…
accessnewswire.com DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmacies To be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026 Program will aim to bring best…
businesswire.com Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and…
benzinga.com DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042 DataMEDS AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
accessnewswire.com DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion in 2025 to $93.4 billion in 2035 Customer Acquisition Plan…
benzinga.com DataMeds AI Regains Compliance With Nasdaq Equity Rule DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its
accessnewswire.com DataMeds Regains Compliance With NASDAQ Listing Standards TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion. DataMEDS AI (NASDAQ:MEDS) shares moved…
defenseworld.net Contrasting Wellgistics Health (NASDAQ:MEDS) & Hims & Hers Health (NYSE:HIMS) Wellgistics Health (NASDAQ: MEDS - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…- benzinga.com DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component On October 13, 2026 (the "Effective Date"), DataMeds AI, Inc. ("DataMeds" or the "Company") entered into an Intellectual Property License and Product and Services Agreement (the "IP License
accessnewswire.com DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI,…- benzinga.com DataMeds AI To Collaborate With REBOOT Health AI To Integrate Its GLP Management Platform Into Its Health Lives Here Mobile App Under License Agreement DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its
accessnewswire.com DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform Platform to be integrated into Health Lives Here app as a subscription offering TAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI,"…
accessnewswire.com DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL /…
benzinga.com DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test DataMeds AI, Inc. (NASDAQ:MEDS) shares are up on Monday as traders react to Medicaid coverage policy news tied to the company's Helomics business and its ChemoFx assay.
benzinga.com DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 141.2% to $2.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 million. DataMEDS AI…
benzinga.com Datameds AI Subsidiary Helomics Receives Medicaid Coverage Determination In Gynecologic Cancers For The ChemoFx Assay In Gynecologic Cancers DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure
accessnewswire.com DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI,"…- benzinga.com DataMeds AI Files DBAs For 'DataMeds SI' And 'Corexa Health SI' The Company also reminded shareholders of record as of the close of business on August 7, 2026 (the "Record Date") that the previously announced distribution (the "Distribution") of Dream Bowl Meme…
accessnewswire.com Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment Healthcare IT Company and its Subsidiary Undertake Action Following US Government's Updated Nomenclature TAMPA, FL / ACCESS Newswire / October 5, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Nexalin Technology (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million. Stablecoin Development (AMEX:SDEV) stock…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-market session. The company's market cap stands at $10.1 million. Stablecoin Development (AMEX:SDEV)…
accessnewswire.com DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches TAMPA, FL / ACCESS Newswire / October 1,…
defenseworld.net Wellgistics Health, Inc. (NASDAQ:MEDS) Stock Short Interest Rises 147.5% Wellgistics Health, Inc. (NASDAQ: MEDS - Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Kodiak Sciences (NASDAQ:KOD) shares moved upwards by 172.3% to $88.08 during Monday's regular session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY)…
benzinga.com Reported Earlier: DataMeds AI, Tollo Health Roll Out Health Lives Here Mobile Application DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence
benzinga.com DataMeds AI Stock Surges on Mobile App Launch DataMeds AI Inc. (NASDAQ:MEDS) shares are surging Monday morning following the launch of its "Health Lives Here" mobile application, a joint initiative with Tollo Health and the NFL Alumni…
benzinga.com DataMeds AI Stock Surges on Mobile App Launch DataMeds AI shares are surging Monday after launching a “Health Lives Here” mobile app with Tollo Health and the NFL Alumni Association.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY)…
accessnewswire.com DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 /…
benzinga.com 'We Don't Know What the Risks Are': GLP-1 Pill Boom Fuels Hundreds of Apps, but Research Is Lagging Oral GLP-1 weight-loss pills are driving a health-tech boom, but research on their safe use is struggling to keep pace.
accessnewswire.com DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data TAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million. Cue Biopharma (NASDAQ:CUE) stock…
accessnewswire.com DataMEDS AI Unveils New Corporate Website Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX)…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million. SkyAI (NASDAQ:SKYA) stock rose…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT)…
- benzinga.com Market-Moving News for September 18th TCRT: 69% | Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors" MEDS: 24% | DataMeds AI Settles Litigation Related To Outstanding Debt…
- benzinga.com DataMeds AI Settles Litigation Related To Outstanding Debt And Receivables Related To The 2023 Wellgistics Agreement; Company Retired ~364,099 MEDS Shares And Paid $450K In Cash Litigation related to outstanding debt and receivables related to the May 11, 2023 Wellgistics, LLC Membership Purchase Interest Agreement (the "Settlement Agreement") that were previously carried on…
accessnewswire.com DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked TAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical…
benzinga.com DataMEDS AI Enters Settlement Agreement On Sept 11, 2026; Expects To Extinguish $19M In Liability From Agreement On September 11, 2026, DataMEDS AI, Inc. (the "Company") entered into a settlement agreement and release (the "Agreement") with Brian Norton, individually and as Seller Representative ("Norton"),- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million. bioAffinity Technologies…